ACVR1 and plasma cell myeloma: Therefore, it was proposed that a reduction in BMPR2 levels could increase ACVR1 complex formation with ACVR2A or ACVR2B, thus enhancing ACVR1-mediated SMAD1/5/8 signalling and myeloma cell death [64].